Bioinjection Performance Review for the Building 100 Area and 4.5 Acre Site at the Pinellas County, Florida, Site
- US Department of Energy, Washington, DC (United States). Office of Legacy Management
- Navarro Research and Engineering, Oak Ridge, TN (United States)
This document provides a summary of a review of the performance of bioinjection activities at the Building 100 Area and the 4.5 Acre Site at the Pinellas County, Florida, Site since 2010, determines how best to optimize future injection events, and identifies the approach for the bioinjection event in 2016 at (1) the 4.5 Acre Site and (2) the Essentra property at the Building 100 Area. Because this document describes the next bioinjection event at the 4.5 Acre Site, it also serves as an addendum to the Interim Remedial Action Plan for Emulsified Edible Oil Injection at the 4.5 Acre Site (DOE 2013). In addition, this document revises the injection layout and injection intervals for the Essentra property that were originally described in the Interim Corrective Measure Work Plan for Source and Plume Treatment at the Building 100 Area (DOE 2014), and is a de facto update of that document. Bioinjection consists of injection of emulsified vegetable oil (EVO) and the microorganism Dehalococcoides mccartyi (DHM; formerly known as Dehalococcoides ethenogenes) into the subsurface to enhance biodegradation of trichloroethene (TCE), dichloroethene (DCE), and vinyl chloride (VC). VC is the only contaminant that exceeds its maximum contaminant level (10 micrograms per liter onsite and 1 microgram per liter onsite) on the 4.5 Acre Site and the Essentra property. Bioinjection was conducted at the 4.5 Acre Site in 2010 and 2013. Approximately 49,900 gallons of EVO and DHM were injected at 95 injection points in February 2010, and approximately 22,900 gallons of EVO and DHM were injected at 46 injection points in July 2013. The injection locations are shown on Figure 1. The goal of bioinjection at the 4.5 Acre Site is to decrease contaminant concentrations to maximum contaminant levels along the west and southwest property boundaries (to meet risk–based corrective action requirements) and to minimize the extent of the contaminant plume in the interior of the site. Bioinjection was conducted at the Building 100 Area in 3 phases from October 2014 through November 2015 (Figures 2–4). Approximately 32,850 gallons of EVO and DHM were injected using 62 temporary injection points in the onsite plumes in October and November 2014, 16,500 gallons were injected using 33 temporary injection points in the offsite plumes in February 2015, and 51,000 gallons were injected beneath the building using 8 horizontal wells in November 2015. The goal of bioinjection at the Building 100 Area is to enhance contaminant biodegradation to stabilize or shrink the contaminant plumes.
- Research Organization:
- US Department of Energy (USDOE), Washington DC (United States). Office of Legacy Management (LM)
- Sponsoring Organization:
- USDOE Office of Legacy Management (LM), Office of Field Operations
- DOE Contract Number:
- LM0000421
- OSTI ID:
- 1260595
- Report Number(s):
- LMS/PIN/N02091
- Country of Publication:
- United States
- Language:
- English
Similar Records
Bioremediation of a Large Chlorinated Solvent Plume, Dover AFB, DE
Treatment of Chlorinated Solvents in Groundwater Beneath an Occupied Building at The Young - Rainey STAR Center (Science, Technology, and Research Center) - 16342